Home / Conditions / Type 1 Diabetes

Type 1 Diabetes

Type 1 Diabetes Treatment and Research: Type 1 diabetes is an autoimmune disorder that destroys pancreatic beta cells. Once called juvenile diabetes, Type 1 is diagnosed most often in children, but can be expressed in adults as well. Incidence is highest among non-hispanic whites, according to the NDEP. Adults with Type 1 make up 5% of all diagnosed diabetes patients.New tools, techniques, treatments, drugs and devices can help you improve outcomes for your patients with Type 1.

Use of SGLT-2 inhibitors As Adjunct to Insulin In People with Type 1 Diabetes

4 days ago Articles, Insulin Therapy Center, SGLT-2 Therapy Center, Type 1 Diabetes, Type 2 Diabetes

Apart from Sotagliflozin’s use in the treatment of people with type 2, SGLT-1 and SGLT-2 inhibitors effects on type 1 currently being explored.

Reducing Insulin Use and Improving Glycemic Control Via Single Dose of Glucagon-Blocking Drug

4 days ago Articles, Blood Glucose Control, Type 1 Diabetes

People with type 1 diabetes receiving once-daily injection of glucagon-blocking drug, REMD-477 can reduce their insulin use considerably and improve blood glucose levels without altering hypoglycemia.

ADA: Oral Insulin May Delay Type 1 Diabetes Onset

2 weeks ago Articles, Insulin Therapy Center, Type 1 Diabetes

In adults with two or more antibodies predicting the development of type 1 diabetes, treatment with daily oral insulin therapy did not prevent development of the disease, but a small subset experienced a 31-month delay in clinical diabetes development.

ADA: Alum-GAD (Diamyd) Vaccine Fails to Prevent Type 1 Diabetes

3 weeks ago Articles, Type 1 Diabetes

Research will still continue due to its safety.

ADA: Effects of REMD-477, a Glucagon-Blocking Drug, in Patients with Type 1 Diabetes

3 weeks ago Articles, Insulin Therapy Center, Type 1 Diabetes

Hmm...this is an interesting development

Results presented in the ADA 77th Scientific Sessions suggests the use of an investigational glucagon-blocking agent can improve glycemic levels and reduce insulin requirements.

ADA: Efficacy and Safety of Hybrid Closed-Loop Systems in Patients with Type 1 Diabetes

3 weeks ago Articles, Blood Glucose Control, Type 1 Diabetes

Results from two studies demonstrate improved glycemic control, reduction in nighttime- and exercise-induced hypoglycemia with the use of hybrid closed-loop systems.

ADA: Cardiovascular Benefits seen with Long-Term Metformin Use in Adults with Type 1 Diabetes

4 weeks ago Articles, Cardiology, Metformin Therapy Center, Type 1 Diabetes

Mature on sofa measuring sugar level in blood using glucometer a

Results from the REMOVAL trial revealed reduction in the risk of cardiovascular disease among other benefits with metformin in type 1 diabetes patients.